JPS4834699B1 - - Google Patents

Info

Publication number
JPS4834699B1
JPS4834699B1 JP43045924A JP4592468A JPS4834699B1 JP S4834699 B1 JPS4834699 B1 JP S4834699B1 JP 43045924 A JP43045924 A JP 43045924A JP 4592468 A JP4592468 A JP 4592468A JP S4834699 B1 JPS4834699 B1 JP S4834699B1
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP43045924A
Other languages
Japanese (ja)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP43045924A priority Critical patent/JPS4834699B1/ja
Publication of JPS4834699B1 publication Critical patent/JPS4834699B1/ja
Pending legal-status Critical Current

Links

JP43045924A 1968-07-03 1968-07-03 Pending JPS4834699B1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP43045924A JPS4834699B1 (fr) 1968-07-03 1968-07-03

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP43045924A JPS4834699B1 (fr) 1968-07-03 1968-07-03

Publications (1)

Publication Number Publication Date
JPS4834699B1 true JPS4834699B1 (fr) 1973-10-23

Family

ID=12732790

Family Applications (1)

Application Number Title Priority Date Filing Date
JP43045924A Pending JPS4834699B1 (fr) 1968-07-03 1968-07-03

Country Status (1)

Country Link
JP (1) JPS4834699B1 (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10988441B2 (en) 2015-03-13 2021-04-27 Valo Early Discovery, Inc. Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
US11147818B2 (en) 2016-06-24 2021-10-19 Infinity Pharmaceuticals, Inc. Combination therapies
US11312718B2 (en) 2011-01-10 2022-04-26 Infinity Pharmaceuticals, Inc. Formulations of (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one
US11433065B2 (en) 2008-01-04 2022-09-06 Intellikine Llc Certain chemical entities, compositions and methods

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11433065B2 (en) 2008-01-04 2022-09-06 Intellikine Llc Certain chemical entities, compositions and methods
US11312718B2 (en) 2011-01-10 2022-04-26 Infinity Pharmaceuticals, Inc. Formulations of (S)-3-(1-(9H-purin-6-ylamino)ethyl)-8-chloro-2-phenylisoquinolin-1(2H)-one
US10988441B2 (en) 2015-03-13 2021-04-27 Valo Early Discovery, Inc. Alpha-cinnamide compounds and compositions as HDAC8 inhibitors
US11147818B2 (en) 2016-06-24 2021-10-19 Infinity Pharmaceuticals, Inc. Combination therapies

Similar Documents

Publication Publication Date Title
AU1946070A (fr)
AU428130B2 (fr)
AU2374870A (fr)
AU5184069A (fr)
AU6168869A (fr)
AU6171569A (fr)
AU429879B2 (fr)
AU416157B2 (fr)
AU2581067A (fr)
AU4811568A (fr)
AU421558B1 (fr)
AU2580267A (fr)
AU3789668A (fr)
AU3224368A (fr)
AR203075Q (fr)
AU4744468A (fr)
AU479393A (fr)
BE708888A (fr)
AU463027A (fr)
AU4503667A (fr)
BE709484A (fr)
AU479894A (fr)
AU4464266A (fr)
AU4270368A (fr)
AU4224469A (fr)